ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peptide Based Gastrointestinal Disorders Therapeutics Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-25B16092
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Peptide Based Gastrointestinal Disorders Therapeutics Global Market Insights and Sales Trends 2024
BUY CHAPTERS

Global Peptide Based Gastrointestinal Disorders Therapeutics Market Research Report 2024

Code: QYRE-Auto-25B16092
Report
March 2024
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Takeda
Ironwood Pharmaceuticals
Astellas Pharma
Allergan plc
Takeda Pharmaceutical

Peptide Based Gastrointestinal Disorders Therapeutics Market

Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.
The global Peptide Based Gastrointestinal Disorders Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Peptide Based Gastrointestinal Disorders Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Peptide Based Gastrointestinal Disorders Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Peptide Based Gastrointestinal Disorders Therapeutics in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Peptide Based Gastrointestinal Disorders Therapeutics include Takeda, Ironwood Pharmaceuticals, Astellas Pharma, Allergan and Takeda Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peptide Based Gastrointestinal Disorders Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Based Gastrointestinal Disorders Therapeutics.

Report Scope

The Peptide Based Gastrointestinal Disorders Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide Based Gastrointestinal Disorders Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Based Gastrointestinal Disorders Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Peptide Based Gastrointestinal Disorders Therapeutics Market Report

Report Metric Details
Report Name Peptide Based Gastrointestinal Disorders Therapeutics Market
Segment by Type
  • Teduglutide
  • Linaclotide
  • Others
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, Ironwood Pharmaceuticals, Astellas Pharma, Allergan, Takeda Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Peptide Based Gastrointestinal Disorders Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Peptide Based Gastrointestinal Disorders Therapeutics Market report?

Ans: The main players in the Peptide Based Gastrointestinal Disorders Therapeutics Market are Takeda, Ironwood Pharmaceuticals, Astellas Pharma, Allergan, Takeda Pharmaceutical

What are the Application segmentation covered in the Peptide Based Gastrointestinal Disorders Therapeutics Market report?

Ans: The Applications covered in the Peptide Based Gastrointestinal Disorders Therapeutics Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Peptide Based Gastrointestinal Disorders Therapeutics Market report?

Ans: The Types covered in the Peptide Based Gastrointestinal Disorders Therapeutics Market report are Teduglutide, Linaclotide, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Teduglutide
1.2.3 Linaclotide
1.2.4 Others
1.3 Market by Application
1.3.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Perspective (2019-2030)
2.2 Peptide Based Gastrointestinal Disorders Therapeutics Growth Trends by Region
2.2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Peptide Based Gastrointestinal Disorders Therapeutics Market Dynamics
2.3.1 Peptide Based Gastrointestinal Disorders Therapeutics Industry Trends
2.3.2 Peptide Based Gastrointestinal Disorders Therapeutics Market Drivers
2.3.3 Peptide Based Gastrointestinal Disorders Therapeutics Market Challenges
2.3.4 Peptide Based Gastrointestinal Disorders Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Revenue
3.1.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peptide Based Gastrointestinal Disorders Therapeutics Revenue
3.4 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio
3.4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2023
3.5 Peptide Based Gastrointestinal Disorders Therapeutics Key Players Head office and Area Served
3.6 Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product Solution and Service
3.7 Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Based Gastrointestinal Disorders Therapeutics Breakdown Data by Type
4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Type (2025-2030)
5 Peptide Based Gastrointestinal Disorders Therapeutics Breakdown Data by Application
5.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2019-2030)
6.2 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2019-2024)
6.4 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2019-2030)
7.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2019-2024)
7.4 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2019-2030)
9.2 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Detail
11.1.2 Takeda Business Overview
11.1.3 Takeda Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.1.4 Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2019-2024)
11.1.5 Takeda Recent Development
11.2 Ironwood Pharmaceuticals
11.2.1 Ironwood Pharmaceuticals Company Detail
11.2.2 Ironwood Pharmaceuticals Business Overview
11.2.3 Ironwood Pharmaceuticals Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.2.4 Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2019-2024)
11.2.5 Ironwood Pharmaceuticals Recent Development
11.3 Astellas Pharma
11.3.1 Astellas Pharma Company Detail
11.3.2 Astellas Pharma Business Overview
11.3.3 Astellas Pharma Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.3.4 Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2019-2024)
11.3.5 Astellas Pharma Recent Development
11.4 Allergan
11.4.1 Allergan Company Detail
11.4.2 Allergan Business Overview
11.4.3 Allergan Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.4.4 Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2019-2024)
11.4.5 Allergan Recent Development
11.5 Takeda Pharmaceutical
11.5.1 Takeda Pharmaceutical Company Detail
11.5.2 Takeda Pharmaceutical Business Overview
11.5.3 Takeda Pharmaceutical Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.5.4 Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2019-2024)
11.5.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Takeda
Ironwood Pharmaceuticals
Astellas Pharma
Allergan plc
Takeda Pharmaceutical
List of Tables
    Table 1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Teduglutide
    Table 3. Key Players of Linaclotide
    Table 4. Key Players of Others
    Table 5. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region (2019-2024)
    Table 9. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region (2025-2030)
    Table 11. Peptide Based Gastrointestinal Disorders Therapeutics Market Trends
    Table 12. Peptide Based Gastrointestinal Disorders Therapeutics Market Drivers
    Table 13. Peptide Based Gastrointestinal Disorders Therapeutics Market Challenges
    Table 14. Peptide Based Gastrointestinal Disorders Therapeutics Market Restraints
    Table 15. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Players (2019-2024)
    Table 17. Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Based Gastrointestinal Disorders Therapeutics as of 2023)
    Table 18. Ranking of Global Top Peptide Based Gastrointestinal Disorders Therapeutics Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Peptide Based Gastrointestinal Disorders Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product Solution and Service
    Table 22. Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Type (2019-2024)
    Table 26. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Type (2025-2030)
    Table 28. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Application (2019-2024)
    Table 30. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Application (2025-2030)
    Table 32. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Takeda Company Detail
    Table 48. Takeda Business Overview
    Table 49. Takeda Peptide Based Gastrointestinal Disorders Therapeutics Product
    Table 50. Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 51. Takeda Recent Development
    Table 52. Ironwood Pharmaceuticals Company Detail
    Table 53. Ironwood Pharmaceuticals Business Overview
    Table 54. Ironwood Pharmaceuticals Peptide Based Gastrointestinal Disorders Therapeutics Product
    Table 55. Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 56. Ironwood Pharmaceuticals Recent Development
    Table 57. Astellas Pharma Company Detail
    Table 58. Astellas Pharma Business Overview
    Table 59. Astellas Pharma Peptide Based Gastrointestinal Disorders Therapeutics Product
    Table 60. Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 61. Astellas Pharma Recent Development
    Table 62. Allergan Company Detail
    Table 63. Allergan Business Overview
    Table 64. Allergan Peptide Based Gastrointestinal Disorders Therapeutics Product
    Table 65. Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 66. Allergan Recent Development
    Table 67. Takeda Pharmaceutical Company Detail
    Table 68. Takeda Pharmaceutical Business Overview
    Table 69. Takeda Pharmaceutical Peptide Based Gastrointestinal Disorders Therapeutics Product
    Table 70. Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2019-2024) & (US$ Million)
    Table 71. Takeda Pharmaceutical Recent Development
    Table 72. Research Programs/Design for This Report
    Table 73. Key Data Information from Secondary Sources
    Table 74. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Teduglutide Features
    Figure 4. Linaclotide Features
    Figure 5. Others Features
    Figure 6. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application: 2023 VS 2030
    Figure 8. Hospital Pharmacies Case Studies
    Figure 9. Retail Pharmacies Case Studies
    Figure 10. Online Pharmacies Case Studies
    Figure 11. Peptide Based Gastrointestinal Disorders Therapeutics Report Years Considered
    Figure 12. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region: 2023 VS 2030
    Figure 15. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Players in 2023
    Figure 16. Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Based Gastrointestinal Disorders Therapeutics as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2023
    Figure 18. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2019-2030)
    Figure 20. United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2019-2030)
    Figure 24. Germany Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. France Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. U.K. Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Italy Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Russia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Nordic Countries Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region (2019-2030)
    Figure 32. China Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. South Korea Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. India Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Australia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2019-2030)
    Figure 40. Mexico Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Brazil Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2019-2030)
    Figure 44. Turkey Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Saudi Arabia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Takeda Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2019-2024)
    Figure 47. Ironwood Pharmaceuticals Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2019-2024)
    Figure 48. Astellas Pharma Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2019-2024)
    Figure 49. Allergan Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2019-2024)
    Figure 50. Takeda Pharmaceutical Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2019-2024)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions